UNSPSC 42295514: Silicone sheetings

In this classification, this commodity indicates a product used as a compositions of various silicone compounds loaded with active pharmaceutical agents, which are suitable for promoting the healing of skin wounds and the reduction or prevention of scarring in a medical setting. US FDA regulates Silicone sheetings under 21 CFR 870.52 and under FDA product code LIX. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42295514 Silicone sheetings, a Commodity code, shows little relevant recent activity in state and local procurement. The three most recent opportunities posted under this code are a law enforcement equipment cooperative purchasing agreement, a cardiac rhythm management implantable devices RFP, and a spinal implants RFP — none of which reflect the nominal commodity scope of silicone sheetings. The mismatch suggests the code has been applied inconsistently or as a catch-all categorization by issuing bodies without direct procurement of the product line itself.

The geographic spread of opportunities spans Texas (University of Texas Health Science Center at San Antonio and University Medical Center of El Paso) and a multi-state cooperative administered by Minnesota (Sourcewell), though these opportunities do not represent actual purchasing demand for silicone sheetings. The law enforcement equipment RFP from Sourcewell, due June 16, 2026, covers participating entities in Washington state and beyond; the CRM implants RFP from El Paso County Hospital District, due April 29, 2026, targets a single 354-bed public teaching hospital; and the spinal implants RFP from UTHSA, due March 10, 2026, is for a 144-bed facility. Absent clarity on whether these codes reflect true procurement intent or administrative tagging error, the code does not present a reliable signal for business development targeting state and local demand for silicone sheetings.